1. |
Yoshida K, Toki F, Takeuchi T, et al. Chronic pancreatitis caused by an autoimmune abnormality[J]. Dig Dis Sci, 1995, 40(7): 1561-1568.
|
2. |
Naitoh I, Nakazawa T, Ohara H, et al. Clinical significance of extrapancreatic lesions in autoimmune pancreatitis[J]. Pancreas, 2010, 39(1): E1-E5.
|
3. |
Kamisawa T, Chari ST, Lerch MM, et al. Recent advances in autoimmune pancreatitis: type 1 and type 2[J]. Gut, 2013, 62(9): 1373-1380.
|
4. |
Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology[J]. Pancreas, 2011, 40(3): 352-358.
|
5. |
Chari ST, Kloeppel G, Zhang L, et al. Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document[J]. Pancreas, 2010, 39(5): 549-554.
|
6. |
Park DH, Kim MH, Chari ST. Recent advances in autoimmune pancreatitis[J]. Gut, 2009, 58(12): 1680-1689.
|
7. |
Proctor RD, Rofe CJ, Bryant T, et al. Autoimmune pancreatitis: an illustrated guide to diagnosis[J]. Clin Radiol, 2013, 68(4): 422-432.
|
8. |
Detlefsen S, Lohr JM, Drewes AM, et al. Current concepts in the diagnosis and treatment of type 1 and type 2 autoimmune pancreatitis[J]. Recent Pat Inflamm Allergy Drug Discov, 2011, 5(2): 136-149.
|
9. |
Zhang L, Chari S, Smyrk T, et al. Autoimmune pancreatitis (AIP) type 1 and type 2: an international consensus study on histopathologic diagnostic criteria[J]. Modern Pathology, 2011, 24(1): 377A.
|
10. |
Matsumoto I, Shirakawa S, Shinzeki M, et al. 18-Fluorodeoxyglucose positron emission tomography does not aid in diagnosis of pancreatic ductal adenocarcinoma[J]. Clin Gastroenterol Hepatol, 2013, 11(6): 712-718.
|
11. |
Okazaki K, Uchida K, Ohana M, et al. Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response[J]. Gastroenterology, 2000, 118(3): 573-581.
|
12. |
Ectors N, Maillet B, Aerts R, et al. Non-alcoholic duct destructive chronic pancreatitis[J]. Gut, 1997, 41(2): 263-268.
|
13. |
Nahon Uzan K, Lévy P, O'Toole D, et al. Is idiopathic chronic pancreatitis an autoimmune disease?[J]. Clin Gastroenterol Hepato, 2005, 3(9): 903-909.
|
14. |
Kim KP, Kim MH, Song MH, et al. Autoimmune chronic pancreatitis[J]. Am J Gastroenterol, 2004, 99(8): 1605-1616.
|
15. |
陈强, 刘迎娣.自身免疫性胰腺炎6例临床分析[J].中国煤炭工业医学杂志, 2012, 15(7): 1042-1044.
|
16. |
唐令诠, 冯昌宁, 蒋智敏.原发性自身免疫性慢性胰腺炎一例报道并文献复习[J].胰腺病学, 2004, 4(1): 39-40.
|
17. |
Horiuchi A, Kawa S, Hamano H, et al. ERCP features in 27 patients with autoimmune pancreatitis[J]. Gastrointest Endosc, 2002, 55(4): 494-499.
|
18. |
Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis[J]. N Engl J Med, 2001, 344(10): 732-738.
|
19. |
Kamisawa T, Funata N, Hayashi Y, et al. Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis[J]. Gut, 2003, 52(5): 683-687.
|
20. |
Procacci C, Carbognin G, Biasiutti C, et al. Autoimmune pancreatitis: possibilities of CT characterization[J]. Pancreatology, 2001, 1(3): 246-253.
|
21. |
Hastier P, Buckley MJ, Dumas R, et al. A study of the effect of age on pancreatic duct morphology[J]. Gastrointest Endosc, 1998, 48(1): 53-57.
|
22. |
李兆申.我国自身免疫性胰腺炎共识意见(草案2012, 上海)[J].中华胰腺病杂志, 2012, 12(6): 410-418.
|
23. |
吴文川, 靳大勇, 王单松, 等.自身免疫性胰腺炎术后激素治疗初探[J].中国普外基础与临床杂志, 2013, 23(2): 23-27.
|
24. |
Wu W, Yao X, Lin C, et al. Should steroid therapy be necessarily needed for autoimmune pancreatitis patients with lesion resected due to misdiagnosed or suspected malignancy?[J]. Gastroenterol Res Pract, 2014(2014): 253471.
|
25. |
distinguish autoimmune pancreatitis from pancreatic cancer[J]. Clin Gastroenterol Hepatol, 2009, 7(10): 1097-1103.
|
26. |
Pearson RK, Longnecker DS, Chari ST, et al. Controversies in clinical pancreatology: autoimmune pancreatitis: does it exist?[J]. Pancreas, 2003, 27(1):1-13.
|